← SynDRA
indolophenanthridine
SynDRA canonical compound SYN0079023 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CALY | DRD1 |
|---|
| Mechanism of action | dopamine receptor agonist |
|---|
Cross-references
Synonyms
- CY 208-243
- 8GJ4UR780B
- CY-208243
- RefChem:919306
- DTXCID7022598
- CY208-243
- Tocris-1249
- Biomol-NT_000032
- UNII-8GJ4UR780B
- BPBio1_001225
- orb1709966
- SCHEMBL9364562
- SCHEMBL29380791
- CHEBI:93399
- GLXC-02973
- GLXC-25866
- HMS3267H13
- HMS3412C06
- HMS3676C06
- AEA99926
- LSM-3788
- EX-A14432
- MFCD06407823
- AKOS024456489
- AT36985
- NCGC00025078-01
- NCGC00025078-02
- CY208243
- DA-52185
- MS-23899
- HY-106094
- CS-0024842
- CY-208,243
- T10908
- SR-01000597425
- SR-01000597425-1
- BRD-K79353516-001-01-9
- BRD-K79353516-001-03-5
Look up indolophenanthridine in the interactive SynDRA portal →